glp-1 atrial fibrillation Risk and Cardiac Rhythm Insights Mechanisms of GLP-1 Receptor Agonists

A large study of 2000 patients without diabetes showed that using Ozempic/Wegovy in addition to diet and exercise for 68 weeks led to a 15% weight loss (1/3 of the participants lost up to 20% of their starting weight.) Those in the control group that were only coached on the lifestyle changes lost 2.4% of their weight

Treatment is simple: stop injecting there and wait

N.ChengW

What this means for you If your state covers Zepbound under Medicaid BCBS Medicaid must cover it If your state does not BCBS Medicaid cannot cover it What regular BCBS employer plans cover doesn't matter here Bottom line: Medicaid coverage depends only on your state's Medicaid rules